AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 31190490
Drug: Venlafaxine hydrochloride
RxNorm normalized name: Venlafaxine Hydrochloride
DrugBank: Venlafaxine (DB00285)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Venlafaxine hydrochloride (75 mg/day in 1st week, 150 mg/day in 2nd week, 225 mg/day from 3rd to 6th week)
Trial: 22176998
Drug: Optimization of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Optimization of medical treatment with β-blockers and angiotensin-converting enzyme inhibitors
Trial: 18318568
Drug: Zoledronic acid
RxNorm normalized name: Zoledronic Acid
DrugBank: Zoledronic acid (DB00399)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Zoledronic acid 4 mg administered as a 15-minute infusion every 3-4 weeks
Trial: 10668449
Drug: NPS 1506
RxNorm normalized name: NP Thyroid Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NPS 1506 (doses ranging from 5-100 mg i.v.)
Trial: 11422263
Drug: Diazolidinyl urea
RxNorm normalized name: Diazolidinyl urea
DrugBank: Diazolidinylurea (DB14173)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazolidinyl urea (DU) patch test at concentrations from 0 to 600 microg/cm(2)
Trial: 31574170
Drug: 1 L
RxNorm normalized name: BLUE 1 LAKE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 L polyethylene glycol plus ascorbic acid with bisacodyl suppository
Trial: 23359968
Drug: UDCA and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UDCA and Fuzheng Huayu Capsule (FHC)
Trial: 21443536
Drug: Certolizumab pegol
RxNorm normalized name: Certolizumab Pegol
DrugBank: Certolizumab pegol (DB08904)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Certolizumab pegol (CZP) 400 mg
Trial: 19733712
Drug: Full drug-eluting
RxNorm normalized name: Fraxinus velutina pollen
DrugBank: Fraxinus velutina pollen (DB10455)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Full drug-eluting stenting (full DES)
Trial: 11502527
Drug: Clinafloxacin 400
RxNorm normalized name: Finafloxacin
DrugBank: Finafloxacin (DB09047)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clinafloxacin 400 mg
Trial: 7961554
Drug: Clozapine treatment
RxNorm normalized name: Clozapine
DrugBank: Clozapine (DB00363)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clozapine treatment (initial 6-week trial)
Trial: 16604429
Drug: 30-session drug
RxNorm normalized name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 60 mg in 1 mL TOPICAL LOTION [SESSION SAVERS SUNSCREEN BROAD SPECTRUM SPF 30 WATER RESISTANT]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30-session drug prevention program in 7th through 9th grades
Trial: 2876744
Drug: 2 g
RxNorm normalized name: Molds 2 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 g sulphasalazine daily for six months
Trial: 1397669
Drug: Typhoid Vi
RxNorm normalized name: Typhoid Vi polysaccharide vaccine
DrugBank: Typhoid Vi polysaccharide vaccine (DB10803)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Typhoid Vi CPS vaccine
Trial: 1530028
Drug: Exogenous human
RxNorm normalized name: Insulin Human
DrugBank: Insulin human (DB00030)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Exogenous human chorionic gonadotropin 5000 IU administered intramuscularly on luteal day +4 (group IV)
Trial: 23059918
Drug: Dexamethasone ointment
RxNorm normalized name: DEXAMETHASONE 0.075 g in 100 g TOPICAL OINTMENT [Seacall Dexamethasone Ointment.]
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Dexamethasone ointment (5 g tube containing 5 mg dexamethasone)
Trial: 7642415
Drug: Alternating chemo-radiotherapy
RxNorm normalized name: Chem-Star Recover
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alternating chemo-radiotherapy (Cisplatin 20 mg/mq and 5-Fluorouracil 200 mg/mq daily for 5 days) with two cycles of 20 Gy/10 fractions/12 days each.
Trial: 11975819
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg of oral sumatriptan
Trial: 4005103
Drug: Desipramine hydrochloride
RxNorm normalized name: Desipramine Hydrochloride
DrugBank: Desipramine (DB01151)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Desipramine hydrochloride (50 mg twice daily)
Trial: 8953680
Drug: ornidazole 40
RxNorm normalized name: ornidazol
DrugBank: Ornidazole (DB13026)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ornidazole 40 mg/kg as a single dose
Trial: 24819761
Drug: Oral bovine
RxNorm normalized name: Pegademase Bovine
DrugBank: Pegademase (DB00061)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral bovine LF 100 mg
Trial: 16123958
Drug: Standard-dose tacrolimus
RxNorm normalized name: Tacrolimus
DrugBank: Tacrolimus (DB00864)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Standard-dose tacrolimus with mycophenolate mofetil
Trial: 12500511
Drug: Intravenous lignocaine
RxNorm normalized name: lidocaine hydrochloride Injectable Solution [Sure-Amp Lignocaine hydrochloride]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous lignocaine 1.5 mg/kg
Trial: 10402336
Drug: Intravenous lignocaine
RxNorm normalized name: lidocaine hydrochloride Injectable Solution [Sure-Amp Lignocaine hydrochloride]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous lignocaine 2 mg/kg
Trial: 29889698
Drug: Perineural dexamethasone
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Perineural dexamethasone (1 mg) with 15 mL bupivacaine 0.5%
Trial: 11851956
Drug: Mass drug
RxNorm normalized name: Xenon, isotope of mass 129
DrugBank: Xenon Xe-129 (DB17386)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mass drug administration (MDA) of diethylcarbamazine (DEC) plus ivermectin (IVR)
Trial: 30705241
Drug: Treatment as
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment as usual (usual speech therapy from local therapist for 6 weeks)
Trial: 19847319
Drug: Glucosamine and
RxNorm normalized name: Glucosamine and Chondroitin Complex
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucosamine and chondroitin (G+C)
Trial: 18447214
Drug: Medication group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication group treated with oral administration of Weilexin
Trial: 1596703
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose alpha-interferon (5 x 10(5) iu, twice a week)
Trial: 6426073
Drug: Sodium cromoglycate
RxNorm normalized name: Sodium cromoglycate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium cromoglycate 20 mg inhaled from a pressurised metered dose inhaler
Trial: 29150312
Drug: Childcare intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Childcare intervention with parental component (CC+HOME)
Trial: 28127507
Drug: Dalfampridine treatment
RxNorm normalized name: Dalfampridine
DrugBank: Dalfampridine (DB06637)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dalfampridine treatment for 12–14 days
Trial: 23449533
Drug: Presence of
RxNorm normalized name: Dna Plasmid Expressing Diphtheria Toxin Triggered By The Presence Of Oncofetal Gene H19
DrugBank: Inodiftagene vixteplasmid (DB16017)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Presence of de novo antibodies
Trial: 10759625
Drug: Cisapride 10
RxNorm normalized name: cisapride 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisapride 10 mg q.d.s.
Trial: 30054173
Drug: Self-led VR
RxNorm normalized name: Prostin VR
DrugBank: Alprostadil (DB00770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Self-led VR exposure therapy followed by the same transition program (after waiting-list)
Trial: 11348533
Drug: melarsoprol treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: melarsoprol treatment
Trial: 28240760
Drug: Focal muscle
RxNorm normalized name: ActivOn Joint & Muscle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Focal muscle vibration therapy combined with progressive modular rebalancing
Trial: 28774880
Drug: Azacitidine 75
RxNorm normalized name: Azacitidine
DrugBank: Azacitidine (DB00928)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Azacitidine 75 mg/m2 intravenously/subcutaneously daily for 3 consecutive days on a 28-day cycle
Trial: 26082889
Drug: Facial affect
RxNorm normalized name: sulfur
DrugBank: Octasulfur (DB09353)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Facial affect discrimination training (20 daily 1-hour sessions over 4 weeks)
Trial: 8747670
Drug: Control solution
RxNorm normalized name: Nausea Control Solution
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control solution (0.02% quinine-hydrochloride)
Trial: 18442722
Drug: RATG induction
RxNorm normalized name: rATG
DrugBank: Antithymocyte immunoglobulin (rabbit) (DB00098)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RATG induction therapy
Trial: 1317643
Drug: 3-mg PGE2
RxNorm normalized name: dinoprostone
DrugBank: Dinoprostone (DB00917)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 3-mg PGE2 vaginal tablet
Trial: 22653382
Drug: Etanercept 50
RxNorm normalized name: etanercept 50 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etanercept 50 mg once weekly for 24 weeks (etanercept/etanercept group)
Trial: 25154195
Drug: High-tone power
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-tone power therapy for 60 minutes for 15 days
Trial: 10518847
Drug: Budesonide inhalation
RxNorm normalized name: Budesonide Inhalation Powder
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Budesonide inhalation suspension (BIS)
Trial: 3524441
Drug: Intranasal rIFN-alpha
RxNorm normalized name: rIFN-alpha-2a
DrugBank: Interferon alfa-2a (DB00034)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal rIFN-alpha A (1.5 X 10(6) IU)
Trial: 1659438
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose naloxone
Trial: 11465625
Drug: Total immunoglobulin
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total immunoglobulin M and total immunoglobulin G concentrations
Trial: 30884986
Drug: Pertuzumab with
RxNorm normalized name: Pertuzumab
DrugBank: Pertuzumab (DB06366)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Pertuzumab with trastuzumab and chemotherapy (THP)
Trial: 20977130
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg of oral meclizine (experimental group)
Trial: 26694939
Drug: Aprepitant 80 mg
RxNorm normalized name: Aprepitant
DrugBank: Aprepitant (DB00673)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aprepitant 80 mg orally with ondansetron 4 mg intravenously
Trial: 21984038
Drug: Clomiphene citrate
RxNorm normalized name: Clomiphene Citrate
DrugBank: Clomifene (DB00882)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clomiphene citrate (100 mg)
Trial: 14607208
Drug: Metoprolol, 50
RxNorm normalized name: Hydrochlorothiazide-Metoprolol, 50 mg-100 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol, 50 mg t.i.d. for 6 months
Trial: 12144575
Drug: Triple therapy
RxNorm normalized name: MigreLief Triple Therapy with Puracol Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple therapy (omeprazole 20 mg, amoxicillin 1 g, clarithromycin 500 mg, all b.d.)
Trial: 12144575
Drug: Quadruple therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quadruple therapy (omeprazole 20 mg b.d., tetracycline chloride 500 mg, metronidazole 500 mg, bismuth subcitrate 120 mg, all t.d.s.)
Trial: 11684628
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C treatment
Trial: 22794217
Drug: 1 mg/mL
RxNorm normalized name: urea 1 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg/mL berberine plus 1% CHX
Trial: 21755540
Drug: Asenapine 5
RxNorm normalized name: asenapine 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Asenapine 5 mg BID
Trial: 12424330
Drug: Tomato sauce
RxNorm normalized name: Nutritional Supplement Oral Food, Solid [DIETARY SPECIALTIES TOMATO SAUCE]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tomato sauce supplementation (30 mg of lycopene/day) for 3 weeks
Trial: 26813209
Drug: Daily 4000
RxNorm normalized name: ombitasvir
DrugBank: Ombitasvir (DB09296)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Daily 4000 IU vitamin D plus a prenatal vitamin containing 400 IU vitamin D
Trial: 12184147
Drug: Mix Group
RxNorm normalized name: Humalog Mix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mix Group (MG) - 50% olein
Trial: 15693870
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human erythropoietin 200 U/kg twice a week, subcutaneously for 6 weeks
Trial: 15693870
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (150 premature infants receiving conventional supportive therapy)
Trial: 12390617
Drug: Buccal prochlorperazine
RxNorm normalized name: prochlorperazine Buccal Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buccal prochlorperazine (PCZ) 3 mg
Trial: 17196475
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of aspirin and ranitidine
Trial: 1519781
Drug: Epidural normal
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural normal saline (20 ml) before surgical incision, followed by epidural fentanyl (4 micrograms/kg, in 20 ml normal saline) infused 15 min after incision.
Trial: 10331327
Drug: Prednisone oral
RxNorm normalized name: prednisone Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisone oral solution
Trial: 30394326
Drug: Dopaminergic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dopaminergic therapy
Trial: 10886272
Drug: Oral isotretinoin
RxNorm normalized name: Isotretinoin
DrugBank: Isotretinoin (DB00982)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral isotretinoin (10‐20 mg three times a week for 2 months)
Trial: 28295959
Drug: Dapagliflozin 10
RxNorm normalized name: dapagliflozin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dapagliflozin 10 mg/d
Trial: 26367217
Drug: melphalan 280
RxNorm normalized name: Melphalan
DrugBank: Melphalan (DB01042)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: melphalan 280 mg/m² (mel280)
Trial: 30577901
Drug: Recovery Line
RxNorm normalized name: Chem-Star Recover
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recovery Line (RL) + Treatment-as-Usual (TAU)
Trial: 22801094
Drug: AS03-adjuvanted vaccines
RxNorm normalized name: respiratory syncytial virus pre-fusion F protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AS03-adjuvanted vaccines
Trial: 18199893
Drug: Piperaquine phosphate
RxNorm normalized name: Piperaquine phosphate
DrugBank: Piperaquine (DB13941)
FDA approved: no
EMA approved: yes
PMDA approved: no
Description: Piperaquine phosphate 1250 mg
Trial: 14648339
Drug: Low-dose enalapril
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose enalapril (0.2 mg/kg daily)
Trial: 14648339
Drug: End of
RxNorm normalized name: End-Zit
DrugBank: Octasulfur (DB09353)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: End of 20 weeks treatment
Trial: 2210807
Drug: Low alcohol
RxNorm normalized name: Low alcohol beer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low alcohol beer (reduced from 537 to 57 ml/week)
Trial: 2210807
Drug: Normal alcohol
RxNorm normalized name: Alcohol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Normal alcohol intake (543 to 557 ml/week)
Trial: 29180278
Drug: Amikacin 15
RxNorm normalized name: amikacin
DrugBank: Amikacin (DB00479)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Amikacin 15 mg/kg
Trial: 31828841
Drug: Slow rehydration
RxNorm normalized name: Slow Sodium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Slow rehydration (intravenous fluid over 12 hours)
Trial: 2658898
Drug: Intravenous porcine
RxNorm normalized name: Secretin porcine
DrugBank: Secretin porcine (DB09527)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous porcine intestinal mucosal heparin
Trial: 26430929
Drug: Synbiotic bread
RxNorm normalized name: Synotic
DrugBank: Fluocinolone acetonide (DB00591)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Synbiotic bread containing Lactobacillus sporogenes (1 × 10^8 CFU) and 0.07 g inulin per 1 g
Trial: 21530322
Drug: Reverse total
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reverse total shoulder arthroplasty with varying humeral versions (0°, 10°, 20° retroversion) and implant thicknesses (‐3, 0, +3 mm from baseline)
Trial: 19099009
Drug: Celecoxib 200
RxNorm normalized name: celecoxib 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celecoxib 200 mg
Trial: 6436890
Drug: Combined doses
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined doses of scopolamine 1.2 mg and nicotine 1.5 mg
Trial: 19673958
Drug: Tissue-engineered bone
RxNorm normalized name: acellular tissue engineered vessel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tissue-engineered bone (test site - Oral Bone, BioTissue, Freiburg, Germany)
Trial: 20177294
Drug: Behavioral therapy
RxNorm normalized name: RelieVRx Virtual Reality Behavioral Therapy for Pain Relief
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Behavioral therapy
Trial: 9049578
Drug: Atenolol 25
RxNorm normalized name: atenolol 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol 25 mg once daily for 7 days
Trial: 15606444
Drug: Comparison of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparison of 12.5 mg and 25 mg oral doses
Trial: 7386801
Drug: Sodium salicylate
RxNorm normalized name: Sodium Salicylate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium salicylate administration in large amounts
Trial: 27231940
Drug: Saline solution
RxNorm normalized name: Unisol 4 Saline Solution
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline solution injection (Control)
Trial: 15111679
Drug: Pergolide 0.25
RxNorm normalized name: pergolide 0.25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pergolide 0.25 to 0.75 mg in the evening for 6 weeks
Trial: 11868930
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate 100 microg and salmeterol 50 microg combination product (FSC) twice daily
Trial: 1320887
Drug: Cyclosporin (CsA)
RxNorm normalized name: Cyclosporine
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporin (CsA) at a dose of 7.5-10 mg/day for the first 6 months, then not exceeding 5 mg/kg/day thereafter
Trial: 18596271
Drug: Epinephrine alone
RxNorm normalized name: Epinephrine
DrugBank: Epinephrine (DB00668)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Epinephrine alone (1 mg)
Trial: 12012079
Drug: Bicarbonate supplement
RxNorm normalized name: Potassium Bicarbonate
DrugBank: Potassium bicarbonate (DB11098)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bicarbonate supplement (0.3 g x kg(‐1) of body mass)
Trial: 23018219
Drug: Ulipristal acetate
RxNorm normalized name: Ulipristal Acetate
DrugBank: Ulipristal (DB08867)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Ulipristal acetate (UPA) 5 or 10 mg daily for 13 weeks
Trial: 1582303
Drug: Cefotaxime 2
RxNorm normalized name: cefotaxime 2000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefotaxime 2 g every 8 h
Trial: 8150763
Drug: Cefepime 2
RxNorm normalized name: cefepime 2000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefepime 2 g every 12 h
Trial: 2581324
Drug: Isoxicam 200
RxNorm normalized name: Piroxicam
DrugBank: Piroxicam (DB00554)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isoxicam 200 mg once daily
Trial: 16292592
Drug: Amitriptyline 25
RxNorm normalized name: amitriptyline 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amitriptyline 25 mg nocturnally administered for 15 days
Trial: 8405014
Drug: 0.150 mg
RxNorm normalized name: LEVOTHYROXINE SODIUM 0.150 mg ORAL TABLET [LEVOTHYROXINE SODIUM]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.150 mg desogestrel + 2.0 mg micronized 17 beta‐oestradiol
Trial: 21876066
Drug: Adjunctive levetiracetam
RxNorm normalized name: Levetiracetam
DrugBank: Levetiracetam (DB01202)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Adjunctive levetiracetam
Trial: 18314112
Drug: Early CC
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early CC group
Trial: 9840608
Drug: PRP-T vaccine
RxNorm normalized name: Haemophilus influenzae type b, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PRP-T vaccine (group 1)
Trial: 7863249
Drug: Nizatidine 10
RxNorm normalized name: Nizatidine
DrugBank: Nizatidine (DB00585)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nizatidine 10 mg/h
Trial: 25487082
Drug: Elosulfase alfa
RxNorm normalized name: Elosulfase alfa
DrugBank: Elosulfase alfa (DB09051)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Elosulfase alfa 2.0 mg/kg administered weekly
Trial: 27300645
Drug: ONO-9054 30
RxNorm normalized name: ONO-2952
DrugBank: ONO-2952 (DB14802)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ONO-9054 30 μg/mL
Trial: 15838525
Drug: 1.5 g
RxNorm normalized name: Vaporizer Vicks 1.5 gal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 g of DHA and 0.75 g of EPA daily for 6 months